Wockhardt shares jump 10% after profitability returns in Q4, margins expand on revenue growth
Wockhardt reported a significant financial turnaround in Q4 FY26, posting a consolidated net profit of ₹166 crore, reversing a net loss of ₹25 crore from the previous year. The company's revenue increased by 30% year-on-year to ₹965 crore, driven by robust growth in biotech operations and key markets, with EBITDA margins expanding to 20.3%.
May 05 2026 12:05:00
Wockhardt shares jump 9% after strong Q4 turnaround, robust FY26 growth
Wockhardt shares surged 9% following a strong turnaround in its March quarter performance. The company reported a positive net profit and substantial revenue growth, with full-year earnings also improving. Key drivers included biotech operations and expansion in emerging markets, alongside new product filings and approvals.
May 05 2026 09:05:00
Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Wockhardt received a monitoring report from CRISIL for Q4 FY26 confirming no deviation in the utilization of QIP proceeds. However, Rs. 162.33 crore allocated for capital expenditure and R&D will now be utilized by FY2028, extending the original timeline.
May 04 2026 18:05:00
Wockhardt Limited
Wockhardt Limited has filed its Monitoring Agency Report for the Qualified Institutional Placement (QIP) proceeds utilization for the quarter ended March 31, 2026. The report confirms that there has been no deviation in the utilization of issue proceeds from the objects as stated in the Placement Document. Additionally, the utilization period for Rs 162.33 crore allocated for capital expenditure and R&D has been extended to FY2028.
May 04 2026 18:05:00
Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Change in Management
Wockhardt appointed three Senior Management Personnel, including a new President for India Business and two Senior Vice Presidents for Biotech and R&D, effective May 4, 2026. These appointments strengthen key leadership areas.
May 04 2026 18:05:00
Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Wockhardt announced its FY26 financial results, with PBT turning positive to Rs.238 Cr. The company also highlighted significant Q4FY26 revenue growth of 30% to Rs.965 Cr and several key product approvals and launches, including MIQNAF® in India.
May 04 2026 15:05:00
Wockhardt Ltd - 532300 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 4Th May, 2026
Wockhardt's board approved FY26 consolidated revenue of ₹3,484 crore and net profit of ₹199 crore, marking a turnaround from a previous year's loss. They also approved a proposal to raise funds through equity or convertible securities, subject to shareholder approval at the AGM.
May 04 2026 15:05:00
Wockhardt Limited
Wockhardt board meeting scheduled for May 4, 2026, to approve audited annual standalone and consolidated financial results for FY26. The board will also consider proposals for fund raising, with the mode of raising funds yet to be ascertained.
Apr 28 2026 16:04:00
Wockhardt Limited
Wockhardt board meeting scheduled for May 4, 2026, to approve audited annual standalone and consolidated financial results for FY26. The board will also consider proposals for fund raising, with the mode of raising funds yet to be ascertained.
Apr 28 2026 16:04:00
Wockhardt Limited
Wockhardt board meeting scheduled for May 4, 2026, to approve audited annual standalone and consolidated financial results for FY26. The board will also consider proposals for fund raising, with the mode of raising funds yet to be ascertained.
Apr 28 2026 15:04:00
Read More